Meet Our Faculty
John J. Warner

PERSONAL INFORMATION |
WORK EXPERIENCE |
2012-Present | Chief Executive Officer, University Hospitals and Clinics |
University of Texas Southwestern Medical Center
6201 Harry Hines Boulevard Dallas, TX 75390 |
|
Lead and direct all activities and operations of the hospitals and clinics associated with UT Southwestern Medical Centre | |
Healthcare | |
2013-Present | Professor of Internal Medicine – Department of Internal Medicine |
University of Texas Southwestern Medical Center
5323 Harry Hines Boulevard Dallas, TX 75390 |
|
Practice medicine as a cardiologist; oversaw the design and development of Clements University Hospital; lead and direct all activities of the hospitals and clinics associated with UT Southwestern Medical Centre | |
Healthcare | |
2008-2012 | Associate Professor of Internal Medicine – Department of Internal Medicine |
University of Texas Southwestern Medical Center
5323 Harry Hines Boulevard Dallas, TX 75390 |
|
Practiced interventional cardiology; oversaw and led the activities of the catheterization clinic | |
Healthcare | |
2003-2008 | Assistant Professor of Medicine – Department of Internal Medicine |
University of Texas Southwestern Medical Center
5323 Harry Hines Boulevard Dallas, TX 75390 |
|
Practiced interventional cardiology | |
Healthcare | |
2002 | Assistant Professor of Medicine – Department of Internal Medicine |
Duke University Medical Center
2301 Erwin Road Durham, North Carolina 27710 |
|
Practiced interventional cardiology and participated in clinical research | |
Healthcare |
EDUCATION AND TRAINING |
2010-2011 | Master of Business Administration | |
University of Tennessee – Knoxville, Tennessee | ||
1999-2000 | Fellow, Interventional Cardiology | |
Duke University Medical Center – Durham, North Carolina | ||
1996-1999 | Fellow, Cardiovascular Disease | |
Duke University Medical Center – Durham, North Carolina | ||
1995-1996 | Chief Resident, Internal Medicine | |
UT Southwestern Medical Center – Dallas, Texas | ||
1993-1995 | Resident, Internal Medicine | |
UT Southwestern Medical Center – Dallas, Texas | ||
1992-1993 | Intern, Internal Medicine | |
UT Southwestern Medical Center – Dallas, Texas | ||
1988 – 1992 | Doctor of Medicine | |
Vanderbilt University School of Medicine- Nashville, Tennessee | ||
1988 – 1992 | Bachelor of Science, Biology | |
Abilene Christian University – Abilene, Texas |
PERSONAL SKILLS |
Mother tongue(s) | English |
Communication skills | ▪ Excellent communication skills are required as I discharge my duties as an executive leader of the hospitals and clinics in a large, busy academic medical centre, and as President of the American Heart Association. |
Organisational / managerial skills | ▪ Executive leadership and business management skills, used in the following capacities: |
· Southeast Zone Operations Leader | |
· Senior Executive Officer, Dallas Hospitals | |
· Chief Executive Officer, University Hospitals and Clinics | |
· Assistant Vice President for Hospital Planning | |
· Medical Director, Doris and Harry W. Bass Jr. Clinical Center for Heart, Lung and Vascular Disease | |
· Chief of Staff, University Hospitals | |
· Director, Cardiology Fellowship Training Program Department of Internal Medicine | |
· Medical Director, University Hospitals – Cardiac Catheterization Laboratory |
Peer Reviewed Journals | · Successful Stenting of Small Coronary Vessels with the Use of Hand-Crimped Palmaz-Schatz Stents. Am J Cardiol 2000 |
· Percutaneous stenting of right pulmonary artery stenosis in fibrosing mediastinitis. Cathet Cardiovasc Intervent 2000 | |
· Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology. J Am Coll Cardiol 2000 | |
· Aortic dissection after angioplasty and stenting of an aortic coarctation: detection by intravascular ultrasonography but not transesophageal echocardiography. J Am Soc Echocardiogr 2001 | |
· Serial echocardiographic evaluation of restenosis after percutaneous mitral commissurotomy. J Am Coll Cardiol 2002 | |
· Comparison of results of percutaneous balloon mitral commissurotomy in patients ≥ 65 years with those in patients aged < 65 years. Am J Cardiol 2001 | |
· Alcohol ablation of the intraventricular septum in symptomatic patients with hypertrophic obstructive cardiomyopathy. North Carolina Medical Journal. 2002 | |
· Comparison of coronary artery dynamics pre- and post- stenting. Journal of Biomechanics 2003 | |
· Paroxysmal cold hemoglobinuria and cardiopulmonary bypass. Ann Thorac Surg 2003 | |
· An improved catheter for difficult-to-engage internal mammary artery grafts. Cathet Cardiovasc Intervent 2003 | |
· Urinary tract infection in patients with acute coronary syndrome: a potential systemic inflammatory connection. Am Heart J 2005 | |
· Mobile cardiac catheterization laboratories increase use of cardiac care in women and African Americans. Am Heart J 2007 | |
· Effect of glucose-insulin-potassium (GIK) infusion on biomarkers of cardiovascular risk in ST elevation myocardial infarction: insight into the failure of GIK. Diab Vasc Dis Res 2007 | |
· Treatment delay in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction: a key process analysis of patient and program factors. Am Heart J 2008 | |
· Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension. Am J Cardiol 2008 | |
· The risk of acute myocardial infarction with etodoloac is not increased with naproxen: a historical cohort analysis of a generic COX-2 inhibitor. J Cardiovascular Pharmacology and Therapeutics 2008 | |
· Systems-based improvement in door-to-balloon times at a large urban teaching hospital: a follow-up study from Parkland Health and Hospital System. Circulation Cardiovascular Quality & Outcomes. 2009 | |
· Long-term outcomes with ambrisentan monotherapy in pulmonary arterial hypertension. Journal of Cardiac Failure. 2010 | |
· Successful use of the TandemHeart® percutaneous ventricular assist device as a bridge to recovery for acute cellular rejection in a cardiac transplant patient. Transplantation Proceedings. 2011. | |
· Developing an ST-elevation myocardial infarction system of care in Dallas County. Am Heart J 2013 | |
· Molecular Cardiology – Histone Deacetylase Inhibition Blunts Ischemia/Reperfusion Injury by Inducing Cardiomyocyte Autophagy. J Am Heart Assoc 2014 | |
Invited Publications, Review Articles, Book Chapters | · Complications of cardiac catheterization. Emergency Medicine July 2000. |
· Cardiac Anesthesia. Principles and Clinical Practice. 2nd Edition. JB Lippincott Co., Philadelphia.2001 | |
· Low Molecular Weight Heparin Use in Acute Coronary Syndromes and Percutaneous Coronary Interventions: An Update. Curr Cardiol Report 2007 | |
· Fibrinolytic therapy. In ACC-Self Assessment Program 7, 2009. | |
· American Heart Association Data Sharing Summit Attendees. Acquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape: A Conference Report from the American Heart Association Data Summit 2015. J Am Heart Assoc. 2015 | |
Editorials | · Angiography at reduced frame rates: how low can you go? Cath Cardiovasc Intervent 1999
· Intracoronary thrombus: an ongoing challenge. J Invas Cardiol 1999;11:488-489. · New tools for assessing microvascular obstruction in patients with ST elevation myocardial infarction. Heart 2004 |
Non-Peer Reviewed Publications/Materials in Print or Other Media | · How Our Community Designed a Better Hospital. Harvard Business Review, ePublication on HBR.org, December 7, 2015.
· How Our Community Designed a Better Hospital. N Engl J Med Catalyst. ePublication December 17, 2015. |
Invited Lectures and Presentations – National/International | · 26th Congress of the Interamerican Society of Cardiology “Casting a Wider Net: Strategies for Beating Cardiovascular Disease in the 21st Century” – 26th Congress of the nteramerican Society of Cardiology |
· 26th Congress of the Interamerican Society of Cardiology “Update of Clinical – Guidelines:Trancatheter Aortic Valve Replacement” | |
· American College of Cardiology – 66th Annual Scientific Session – “Academic Medical Centers Under Siege: Facing the New Realities” | |
· Society of Hospital Medicine Annual Scientific Sessions – “Acute Coronary Syndromes: Best Evaluation and Managementz’ | |
· Society of Cardiac Anesthesia Annual Scientific Sessions – “CABG Versus Stent: Medicine’s (not-so) New Great Debate” | |
Indiana University Medical Center Cardiology Grand Rounds – “The 2007 Unstable Angina/ NSTEMI Guidelines for Anticoagulants and Anti-platelet Drugs: The Evidence Behind the Guidelines and Future Directions” | |
· Southern Thoracic Surgery Society Annual Meeting – Pro/Con Debate with Dr. Robert Guyton, Chairman, Cardiac Surgery, Emory Medical Center – “CABG is the Preferred Treatment for Multi-Vessel Disease” | |
· American Heart Association Scientific Sessions Symposium – “Perfect Drug, Perfect Storm: COX-2 Drugs” | |
· University of Oklahoma Cardiology Grand Rounds – “Anti-Thrombotic Therapy in Acute Coronary Syndromes” | |
Invited Lectures and Presentations – Regional | · UT Southwestern Internal Medicine Grand Rounds -“Two Decades of Coronary Artery Stents: Lessons Learned and What’s Next” |
· UT Southwestern Cardiology Grand Rounds – “Dual Anti-Platelet Therapy Following Drug-Eluting Stents” | |
· Bixby Foundation Cardiovascular Symposium – “Update in Acute Coronary Syndromes” | |
· UT Southwestern Cardiology Grand Rounds – “Anti-platelet Therapy in Patients with an Indication for Warfarin” | |
· Overland Park Diabetes and Cardiovascular Symposium – “Drug-Eluting Stents or Bare-Metal Stents?” | |
· UT Southwestern Medical Grand Rounds – “Stents, Surgery or Statins: Medical Therapy or Revascularization for Stable – Coronary Artery Disease” | |
· UT Southwestern Cardiology Grand Rounds – “Who Gets What: PCI versus CABG in 2007?” | |
· UT Southwestern Cardiology Grand Rounds – Stent Thrombosis and Anti-Platelet Therapy: Clinical Dilemmas” | |
· Texas Academy of Family Physicians Fall Conference – “Treatment of Unstable Angina” | |
· UT Southwestern Cardiology Grand Rounds – “COX-2 Drugs and Cardiovascular Risk: Bad Drugs, Bad Science or Both?” | |
· UT Southwestern Medical Center Update in Internal Medicine – “Coronary Revascularization in the Era of Drug-Eluting Stents” | |
· Baylor Heart and Vascular Institute Cardiology Grand Rounds – “Low Molecular Weight Heparins in Acute Coronary Syndromes” | |
· UT Southwestern Medicine Grand Rounds – “Stents or Surgery: Coronary Revascularization in the Era of Drug- Eluting Stents” | |
· 23rd Annual Advances in Cardiology Symposium – “Low molecular Weight Heparin in Acute Coronary Syndromes” | |
· Excellence in Cardiovascular and Arrhythmia Therapy Conference – “Acute Myocardial Infarction and Making Sense out of Anticoagulants” | |
· UT Southwestern Family Medicine Grand Rounds – “The Treatment of Pain and Inflammation in Cardiac Patients” | |
· UT Southwestern Cardiology Grand Rounds – “Drug-Eluting Stents” | |
· Kansas University/Mid-America Cardiology 22nd Annual Fall Conference – “Evidence-Based Care of Acute Coronary Syndromes” | |
· Medical Grand Rounds, South Austin Hospital – “Evidence-Based Care of Acute Coronary Syndromes” | |
· Texas Tech University Health Sciences Center – Advances in Cardiology for the Primary Care Provider – “The ACC/AHA Guidelines: Recommendations for the Management of Patients with Unstable Angina and Non-ST Segment Elevation Myocardial Infarction” | |
· Duke University Medical Center Cardiology Grand Rounds – “Beyond the Oculostenotic Reflex: Risk Stratification during the Coronary Angiogram” | |
· Danville Regional Medical Center Cardiovascular Symposium – “New Approaches to the Treatment of Hypertrophic Obstructive Cardiomyopathy” | |
· Duke University Medical Center Cardiovascular Research Conference – “Defining Success in the Cardiac Catheterization Lab” | |
Panels and Workshops | · American College of Cardiology – 66th Annual Scientific Session -Presenter/Panelist: “Overcoming Today’s Challenges to Launching and Growing Your Academic Medical Career: An Interactive Tutorial” |
· National Academy of Medicine – Leadership Consortium for a Value & Science-Driven Health System – Patient-Centered Outcomes Research Institute – Presenter/Panelist: “Accelerating Clinical Knowledge Generation and Use: Strategic Scale and Spread” | |
· Paul M. Bass Center for Neurosurgical Innovation Symposium – Panelist: “Stroke: The North Texas Health Care Challenge” | |
· Texas Tribune Symposium – Panelist: “Transforming Texas Hospitals” | |
· Institute of Medicine of the National Academy of Sciences – Integrating Research and Practice: Health System Leaders Working Toward High-Value Care – Panelist: “Multi-Use Infrastructure for Continuous Learning” | |
· Texas Tribune Symposium – Panelist: “Major Issues in Health Care in Texas” | |
· Duke Heart Center 25th Anniversary Scientific Symposium – Panelist: “Health Care 2024: What Can Patients and Physicians Anticipate?” | |
Honours & Awards | · Becker’s Hospital Review – Physician Leaders of Hospitals and Health Systems – 110 Physician Leaders to Know ; 2016-2017 |
· D CEO Magazine – The Dallas 500: The Most Powerful Business Leaders in DFW; 2016-2017 | |
· D Magazine – Best Doctors in Dallas, Cardiology; 2016, 2007-2012, 2005 | |
· Dallas Business Journal – Who’s Who in Healthcare; 2014 | |
· Castle Connolly America’s Top Doctors; 2008-2017 | |
· Texas Monthly Magazine Super Doctor; 2007-2017 | |
· Duke Clinical Research Institute Award for Outstanding Fellow Contribution to Clinical Research; 2000 | |
· Guidant Fellowship in Interventional Cardiology, Duke University Medical Center; 1999 | |
· Walter L. Floyd Endowed Fellowship in Cardiology, Duke University Medical Center; 1998 | |
· Dan May Summer Research Scholarship, Vanderbilt School of Medicine; 1988-1989 | |
· Roy Willingham Health Professions Award (outstanding pre-medical graduate), Abilene Christian University; 1988 | |
· Alpha Chi Honor Society, Abilene Christian University; 1986 |